findmyKOL
Clinical trialNCT05470400TerminatedPhase 1Interventional

A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment44HIV
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Atlanta - Hope Clinic

    Atlanta, Georgia, United States

  • Bidmc Vcrs [32077]

    Boston, Massachusetts, United States

  • Columbia P&s Crs [30329]

    New York, New York, United States

  • New York Blood Center Crs [31801]

    New York, New York, United States

  • University of Rochester Vaccines To Prevent Hiv Infection Crs [31467]

    Rochester, New York, United States

  • University of Pittsburgh Crs [1001]

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Aug 2022
Primary completion
24 Jan 2024
Completion
24 Jan 2024
Last update posted
23 Apr 2026
Registered enrollment
44
Registry id
NCT05470400

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.